220 related articles for article (PubMed ID: 27094368)
1. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
4. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
Lu J; Sun D; Liu Z; Li M; Hong H; Liu C; Gao S; Li H; Cai Y; Chen S; Li Z; Ye J; Liu P
Transl Res; 2016 Jun; 172():96-112.e6. PubMed ID: 27016702
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
7. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
8. Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.
Liu LB; Huang SH; Qiu HL; Cen XF; Guo YY; Li D; Ma YL; Xu M; Tang QZ
Br J Pharmacol; 2022 Sep; 179(18):4516-4533. PubMed ID: 35727596
[TBL] [Abstract][Full Text] [Related]
9. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
Duan Y; Zhou B; Su H; Liu Y; Du C
Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
[TBL] [Abstract][Full Text] [Related]
10. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
11. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
12. The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy.
Pillai VB; Samant S; Hund S; Gupta M; Gupta MP
Aging (Albany NY); 2021 May; 13(9):12334-12358. PubMed ID: 33934090
[TBL] [Abstract][Full Text] [Related]
13. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin.
Davidson SM; Townsend PA; Carroll C; Yurek-George A; Balasubramanyam K; Kundu TK; Stephanou A; Packham G; Ganesan A; Latchman DS
Chembiochem; 2005 Jan; 6(1):162-70. PubMed ID: 15593114
[TBL] [Abstract][Full Text] [Related]
15. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
Zhang DH; Zhang JL; Huang Z; Wu LM; Wang ZM; Li YP; Tian XY; Kong LY; Yao R; Zhang YZ
J Am Heart Assoc; 2020 Nov; 9(22):e017751. PubMed ID: 33170082
[TBL] [Abstract][Full Text] [Related]
17. EGCG inhibits pressure overload-induced cardiac hypertrophy via the PSMB5/Nmnat2/SIRT6-dependent signalling pathways.
Cai Y; Yu SS; He Y; Bi XY; Gao S; Yan TD; Zheng GD; Chen TT; Ye JT; Liu PQ
Acta Physiol (Oxf); 2021 Apr; 231(4):e13602. PubMed ID: 33315278
[TBL] [Abstract][Full Text] [Related]
18. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
19. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
20. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
